Erratum : Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in st-segment elevation myocardial infarction (JACC: Cardiovascular Interventions (2015) 8 (18997))
10.1016/j.jcin.2015.01.005
Saved in:
Main Authors: | Brugaletta, S., Gori, T., Low, A.F., Tousek, P., Pinar, E., Gomez-Lara, J., Scalone, G., Schulz, E., Chan, M.Y., Kocka, V., Hurtado, J., Gomez-Hospital, J.A., M?nzel, T., Lee, C.-H., Cequier, A., Vald?s, M., Widimsky, P., Serruys, P.W., Sabat?, M. |
---|---|
Other Authors: | MEDICINE |
Format: | Others |
Published: |
Elsevier
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/123874 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-Year results of a propensity score matching comparison: the BVS-examination study (Bioresorbable Vascular Scaffold-a clinical
by: Brugaletta, S., et al.
Published: (2016) -
ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison
by: Brugaletta, Salvatore, et al.
Published: (2021) -
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
by: Suwannasom P., et al.
Published: (2017) -
Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: From bench to clinical use
by: Yohei Sotomi, et al.
Published: (2018) -
Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: From bench to clinical use
by: Yohei Sotomi, et al.
Published: (2018)